Ambassadors Role
|
Organize Regional Ecosystem:
•Create partnerships with regional organizations (industry, government, academic, etc.). Recruit regional sponsors •Host regional events to bring partners and potential participants together to promote challenges and participation •Recruit local mentors to train and coach teams and startups |
Recruit Local Entrepreneurship Groups:
•Recruit participants and teams from regional industry, entrepreneurship, and academic groups •Organize roadshows at local universities to present challenge and formulate teams •Host MeetUps to encourage collaboration between local scientific and entrepreneur communities and recruit teams |
Benefits to Ambassador Role:
•Receive equity in startups created out of Ambassadors’ region •Expand entrepreneurial and industry network •Create a significant impact on innovation in the region |
Galvanize and Maximize
Maximize ecosystem resources to position local teams and startups as a leaders for industrial growth
Maximize ecosystem resources to position local teams and startups as a leaders for industrial growth
Current Ambassadors
Grace Lee, Founder at Health Enovations
Grace Lee is a serial entrepreneur, angel investor and subject matter expert with 20+ years of experience in product development and launch, predictive analytics, business design, healthcare, technology innovations, and customer, patient, & business data analytics in Pharmaceutical, Biotechnology, and Healthcare focusing on cancer, CNS conditions, and automating predictive analytics. She is the founder of Health Enovations, Inc., Wishpoints, Inc., and Health Education and Advocacy League. She has traveled to over 80 countries and is focused on improving travel and local businesses in emerging regions through predictive analytics.
She is a former founder of and recently founded Health Enovation. She serves as an advisory board member to startup companies with focuses on social impact, healthcare, and travel. She is a Pipeline Angel Investor who evaluates, invests, leads due diligence on behalf of other investors, and advises companies on startup business design and execution in health tech, travel tech, and female founded businesses. She has launched Neurontin, Lipitor & Viagra, and developed and Groot to achieve FDA approval for new drugs like Namenda, Lexapro, and Apremilast. She has built health advocacy organizations that have been running for over 20 years. She has designed and authored national disease management and health technology strategies for FDA and Qatar Supreme Council of Health. She has been an advisor for CMOS and VPs on redesigning their multinational corporations and technology to meet new regulatory requirements such as Good Pharmacovigilance Practices. She founded Health Enovation, Inc to advise startups in the health tech space on how to design sustainable businesses, profitable models, and compliant to regulatory and legal requirements.
Grace Lee is a serial entrepreneur, angel investor and subject matter expert with 20+ years of experience in product development and launch, predictive analytics, business design, healthcare, technology innovations, and customer, patient, & business data analytics in Pharmaceutical, Biotechnology, and Healthcare focusing on cancer, CNS conditions, and automating predictive analytics. She is the founder of Health Enovations, Inc., Wishpoints, Inc., and Health Education and Advocacy League. She has traveled to over 80 countries and is focused on improving travel and local businesses in emerging regions through predictive analytics.
She is a former founder of and recently founded Health Enovation. She serves as an advisory board member to startup companies with focuses on social impact, healthcare, and travel. She is a Pipeline Angel Investor who evaluates, invests, leads due diligence on behalf of other investors, and advises companies on startup business design and execution in health tech, travel tech, and female founded businesses. She has launched Neurontin, Lipitor & Viagra, and developed and Groot to achieve FDA approval for new drugs like Namenda, Lexapro, and Apremilast. She has built health advocacy organizations that have been running for over 20 years. She has designed and authored national disease management and health technology strategies for FDA and Qatar Supreme Council of Health. She has been an advisor for CMOS and VPs on redesigning their multinational corporations and technology to meet new regulatory requirements such as Good Pharmacovigilance Practices. She founded Health Enovation, Inc to advise startups in the health tech space on how to design sustainable businesses, profitable models, and compliant to regulatory and legal requirements.
Dayna Sessa, Founder at Datanomy
Dayna Sessa is the founder and CEO of Datanomy and a pioneer in big data analytics in healthcare.
Dayna was a biomedical engineer and management consultant prior to starting Datanomy, which is bringing patients back to the center of healthcare by making technology work for clinicians in more efficient, less obtrusive and predictive ways. Datanomy provides healthcare organizations with data driven insights and tools. Dayna Sessa is an inaugural WENYC Mentor for the City of New York's initiative to empower women to start and grow companies. She is an advisor to the Clinton Foundation Digital Health Initiative and a contributor to the Huffington Post about data and entrepreneurship. She regularly speaks about healthcare technology, data analytics, startups, & data-driven business strategy at universities, organizations and conferences across the country. Dayna sits on the boards of Clinton Foundation 2030, Friends of Mount Sinai & Porvenir, a STEM-ED non-profit she co-founded. She has received honors from the Tory Burch Foundation, Goldman Sachs 10,000 Small Businesses & was a top 10 US finalist for the Cartier Women's Initiative.
Dayna Sessa is the founder and CEO of Datanomy and a pioneer in big data analytics in healthcare.
Dayna was a biomedical engineer and management consultant prior to starting Datanomy, which is bringing patients back to the center of healthcare by making technology work for clinicians in more efficient, less obtrusive and predictive ways. Datanomy provides healthcare organizations with data driven insights and tools. Dayna Sessa is an inaugural WENYC Mentor for the City of New York's initiative to empower women to start and grow companies. She is an advisor to the Clinton Foundation Digital Health Initiative and a contributor to the Huffington Post about data and entrepreneurship. She regularly speaks about healthcare technology, data analytics, startups, & data-driven business strategy at universities, organizations and conferences across the country. Dayna sits on the boards of Clinton Foundation 2030, Friends of Mount Sinai & Porvenir, a STEM-ED non-profit she co-founded. She has received honors from the Tory Burch Foundation, Goldman Sachs 10,000 Small Businesses & was a top 10 US finalist for the Cartier Women's Initiative.
Jason E. Barkeloo, Chairman & Founder, Open Therapeutics
Jason E. Barkeloo is the Chairman and Founder of Open Therapeutics. His motto is, “It’s not why we can’t. It’s how we can.” Barkeloo is a serial entrepreneur with a strong reputation for building sound businesses and transitioning them to professional management. Having transitioned Open Therapeutics to a professional management team, Barkeloo continues to remain involved in Open Therapeutics from a strategic perspective. His two enterprises prior to Open Therapeutics include Pilus Energy, a synthetic bacterial based platform which he sold to a reputable company, and Somatic Digital, a human/computer interface company that developed the Touch User Interface (TUI). His entrepreneurial ventures include several technologies for education and financial services. Mr. Barkeloo has served in the US Army both in air defense and medical laboratory operations. He has a Bachelor of Arts from The Ohio State University, a Master of Arts in Education specializing in sciences and social studies from the McGregor School of Antioch University, and Ph.D. coursework in Leadership and Organizational Change from Antioch University.
Jason E. Barkeloo is the Chairman and Founder of Open Therapeutics. His motto is, “It’s not why we can’t. It’s how we can.” Barkeloo is a serial entrepreneur with a strong reputation for building sound businesses and transitioning them to professional management. Having transitioned Open Therapeutics to a professional management team, Barkeloo continues to remain involved in Open Therapeutics from a strategic perspective. His two enterprises prior to Open Therapeutics include Pilus Energy, a synthetic bacterial based platform which he sold to a reputable company, and Somatic Digital, a human/computer interface company that developed the Touch User Interface (TUI). His entrepreneurial ventures include several technologies for education and financial services. Mr. Barkeloo has served in the US Army both in air defense and medical laboratory operations. He has a Bachelor of Arts from The Ohio State University, a Master of Arts in Education specializing in sciences and social studies from the McGregor School of Antioch University, and Ph.D. coursework in Leadership and Organizational Change from Antioch University.
Beau Buck, Managing General Partner at Narrative
Beau Buck is a proven venture development person. Companies, funded researchers, and other entrepreneurs work with him when they want to accelerate their progress by connecting them with investors, institutions, entrepreneurs, strategic partners, board members and industry leaders. Mr. Buck has been a mentor with various entities including CAI for some years.
Beau Buck is a proven venture development person. Companies, funded researchers, and other entrepreneurs work with him when they want to accelerate their progress by connecting them with investors, institutions, entrepreneurs, strategic partners, board members and industry leaders. Mr. Buck has been a mentor with various entities including CAI for some years.
Joe Milam, CEO | Founder at AngelSpan
Joe Milam is the Founder at AngelSpan. Mr. Milam has expertise in CSFB HOLT's CFROI framework. He is a Member of the Board of Directors of Legacy Capital Management, Inc., and was previously the President, where he was responsible for the formation and development of the firm since 1985. Mr. Milam holds a B.S. degree in Finance from California State University, Chico.
Mr. Milam founded AngelLegacy, LLC., in 2000, an early platform that provided an affinity-based funding portal, a record keeping platform and an investor relations tool. Holds a patent on an algorithm matching investors with entrepreneurs using the Bell-Mason Diagnostic framework that included QSB criteria, due diligence requirements and affinity preferences. With a background in financial analysis, portfolio design and management, financial markets, angel investing (ask him how The Band of Angels really started), an extended tenure at 3000 Sand Hill Road (clients included senior management of Wilson, Sonsini, Goodrich & Rosati, Sequoia Capital, Silicon Valley Bank), Mr. Milam offers unique and historical insights in the psychology and motivations of angel investors.
Joe Milam is the Founder at AngelSpan. Mr. Milam has expertise in CSFB HOLT's CFROI framework. He is a Member of the Board of Directors of Legacy Capital Management, Inc., and was previously the President, where he was responsible for the formation and development of the firm since 1985. Mr. Milam holds a B.S. degree in Finance from California State University, Chico.
Mr. Milam founded AngelLegacy, LLC., in 2000, an early platform that provided an affinity-based funding portal, a record keeping platform and an investor relations tool. Holds a patent on an algorithm matching investors with entrepreneurs using the Bell-Mason Diagnostic framework that included QSB criteria, due diligence requirements and affinity preferences. With a background in financial analysis, portfolio design and management, financial markets, angel investing (ask him how The Band of Angels really started), an extended tenure at 3000 Sand Hill Road (clients included senior management of Wilson, Sonsini, Goodrich & Rosati, Sequoia Capital, Silicon Valley Bank), Mr. Milam offers unique and historical insights in the psychology and motivations of angel investors.
Ricardo Martínez, Adjunct Professor of Finance and Business Management at Ana G. Méndez University
Ricardo Martínez is a Finance & Marketing Strategist with 15 years of experience. Mr. Martínez obtained a MS in Finance from Johns Hopkins University and currently assists faculty and MBA students at Johns Hopkins Carey Business School’s CityLab.
Ricardo Martínez is a Finance & Marketing Strategist with 15 years of experience. Mr. Martínez obtained a MS in Finance from Johns Hopkins University and currently assists faculty and MBA students at Johns Hopkins Carey Business School’s CityLab.
Erica Waite, CEO at Ikove Venture Partners
Erica Waite is the CEO of Ikove Venture Partners, a technology-focused venture development firm in Columbus, OH. Erica oversees the convergence of pipeline, fundraising, operations, strategy, and business development efforts for Ikove and many of its affiliate companies. She works closely with technical teams, investors, advisors, and industry contacts to create successful startups. Erica previously served as the Director of Market Intelligence and Commercialization Strategy Services for the Technology Entrepreneurship and Commercialization (TEC) Institute. She has worked on the funding, development, and commercialization of early stage technologies for over ten years. Erica holds a Master of Science degree in Pathology from Case Western Reserve University and a Bachelor of Science degree in Biochemistry from The Ohio State University. She also has an MBA from OSU’s Fisher College of Business with a specialization in Entrepreneurship and New Business Ventures.
Erica Waite is the CEO of Ikove Venture Partners, a technology-focused venture development firm in Columbus, OH. Erica oversees the convergence of pipeline, fundraising, operations, strategy, and business development efforts for Ikove and many of its affiliate companies. She works closely with technical teams, investors, advisors, and industry contacts to create successful startups. Erica previously served as the Director of Market Intelligence and Commercialization Strategy Services for the Technology Entrepreneurship and Commercialization (TEC) Institute. She has worked on the funding, development, and commercialization of early stage technologies for over ten years. Erica holds a Master of Science degree in Pathology from Case Western Reserve University and a Bachelor of Science degree in Biochemistry from The Ohio State University. She also has an MBA from OSU’s Fisher College of Business with a specialization in Entrepreneurship and New Business Ventures.
Ryan Micheletti, Director of Global Operations at Founder Institute
After six years as a Reserve for the California National Guard, Ryan Micheletti decided to pursue his dream of helping Veteran entrepreneurs access the resources they need to make their startups a success. As Head of Operations at VET-TECH, Mr. Micheletti helps Veterans take their technology startups to the next level. The company provides access to resources in Silicon Valley, as well as mentoring and advice on corporate partnerships. Mr. Micheletti is Director of Global Operations for the Founder Institute, the world’s largest startup launch program, based in 150 cities globally. Mr. Micheletti runs a 14-week entrepreneurship program aimed at transforming early-stage startups into fully formed companies and fund free places for eligible Veterans.
After six years as a Reserve for the California National Guard, Ryan Micheletti decided to pursue his dream of helping Veteran entrepreneurs access the resources they need to make their startups a success. As Head of Operations at VET-TECH, Mr. Micheletti helps Veterans take their technology startups to the next level. The company provides access to resources in Silicon Valley, as well as mentoring and advice on corporate partnerships. Mr. Micheletti is Director of Global Operations for the Founder Institute, the world’s largest startup launch program, based in 150 cities globally. Mr. Micheletti runs a 14-week entrepreneurship program aimed at transforming early-stage startups into fully formed companies and fund free places for eligible Veterans.
Abram Becker, Mentor in Residence, Discovery to Product, University of Wisconsin-Madison
Abram Becker is a Mentor in Residence at Discovery to Product, a major partnership between UW-Madison and the Wisconsin Alumni Research Foundation (WARF), focused on entrepreneurship and building on a long history of collaboration by the University and WARF to move UW-Madison technology and innovation to market. Mr. Becker obtained a BS in Biology and an MBA from Duke University.
Abram Becker is a Mentor in Residence at Discovery to Product, a major partnership between UW-Madison and the Wisconsin Alumni Research Foundation (WARF), focused on entrepreneurship and building on a long history of collaboration by the University and WARF to move UW-Madison technology and innovation to market. Mr. Becker obtained a BS in Biology and an MBA from Duke University.
James Mainord, Chief Operations Officer at Ikove Venture Partners
James Mainord is a Managing Director and Chief Operations Officer for Ikove Venture Partners (IVP). IVP is a "Startup Nursery" that focuses on identifying concept technologies currently in development at leading US Universities and Labs and creates the right ecosystem for those technologies to develop into successful startups. Mr. Mainord leads IVP efforts in Dayton and over sees operations in Columbus. Mr. Mainord graduated in 2003 with a Bachelor of Arts in Political Science from Brigham Young University and in 2006 received his Juris Doctorate from the University Of Dayton School of Law. Shortly after graduation he joined Avetec, a Springfield, Ohio federal research firm, and worked as Director of Legal Affairs and Director of Business Development. While at Avetec he led a variety of projects that included high performance computing research activity, fiber optic network construction, turbine engine modeling and simulation, and coal-to-liquids technology. He also oversaw and reviewed all contractual and legal matters. In 2013 Mr. Mainord led a corporate merger between Avetec and Beavercreek-based intelligence training firm ATIC. Upon successful completion of this merger Mr. Mainord transitioned to Vice-President of Strategic Development for ATIC where he oversaw the Springfield operations and strategic development opportunities. He later continued in this role for Wright State Research Institute.
James Mainord is a Managing Director and Chief Operations Officer for Ikove Venture Partners (IVP). IVP is a "Startup Nursery" that focuses on identifying concept technologies currently in development at leading US Universities and Labs and creates the right ecosystem for those technologies to develop into successful startups. Mr. Mainord leads IVP efforts in Dayton and over sees operations in Columbus. Mr. Mainord graduated in 2003 with a Bachelor of Arts in Political Science from Brigham Young University and in 2006 received his Juris Doctorate from the University Of Dayton School of Law. Shortly after graduation he joined Avetec, a Springfield, Ohio federal research firm, and worked as Director of Legal Affairs and Director of Business Development. While at Avetec he led a variety of projects that included high performance computing research activity, fiber optic network construction, turbine engine modeling and simulation, and coal-to-liquids technology. He also oversaw and reviewed all contractual and legal matters. In 2013 Mr. Mainord led a corporate merger between Avetec and Beavercreek-based intelligence training firm ATIC. Upon successful completion of this merger Mr. Mainord transitioned to Vice-President of Strategic Development for ATIC where he oversaw the Springfield operations and strategic development opportunities. He later continued in this role for Wright State Research Institute.
Krystle Karoscik, Clinical Research Project Manager at Children's Hospital of Philadelphia
Krystle Karoscik is Clinical Research Project Manager at Children's Hospital of Philadelphia and has 10 years of project management experience in academic medicine, primarily focused on outcomes research and strategy in neuroscience and oncology, as well as several years of healthcare consulting/business development experience as a team manager for the Penn Biotech Group, Wharton.
Source: Cancer Moonshot Stakeholder Engagement Sheet
Krystle Karoscik is Clinical Research Project Manager at Children's Hospital of Philadelphia and has 10 years of project management experience in academic medicine, primarily focused on outcomes research and strategy in neuroscience and oncology, as well as several years of healthcare consulting/business development experience as a team manager for the Penn Biotech Group, Wharton.
Source: Cancer Moonshot Stakeholder Engagement Sheet
